RUSH UNIVERSITY MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1837-01-01

Employees: -

Market Cap: -

Website: https://www.rush.edu/

Clinical Trials

Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation

Not Applicable

Completed

Conditions: Menopause
Abdominal Obesity
Obesity
Overweight
Visceral Adipose Tissue Accumulation

Interventions: Behavioral: Multi-level intervention

First Posted Date: 2013-01-29

Last Posted Date: 2016-04-27

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 71

Registration Number: NCT01778712

Locations: 🇺🇸
Department of Preventive Medicine, Rush University Medical Center, Chicago, Illinois, United States

Preoperative Cognitive Therapy for Improving Health Outcomes After TKA in High-risk Catastrophizing Subjects

Not Applicable

Completed

Conditions: Catastrophization

Interventions: Other: Cognitive Therapy
Other: Routine Care

First Posted Date: 2013-01-21

Last Posted Date: 2022-06-28

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 160

Registration Number: NCT01772329

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Oral Antibiotics After 2-Stage Revision for Infected Total Hip Arthroplasty and Total Knee Arthroplasty

Not Applicable

Completed

Conditions: Prosthesis-Related Infections

Interventions: Other: Oral Antibiotics

First Posted Date: 2013-01-04

Last Posted Date: 2021-08-25

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 185

Registration Number: NCT01760863

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸
Central DuPage Hospital, Winfield, Illinois, United States
🇺🇸
Vanderbilt, Nashville, Tennessee, United States

and more 1 locations

Phase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant Astrocytomas

Phase 1

Terminated

Conditions: Gliosarcoma
Glioblastoma
Anaplastic Astrocytoma
Anaplastic Oligoastrocytoma
Anaplastic Ependymoma
Anaplastic Oligodendroglioma

Interventions: Drug: AXL1717

First Posted Date: 2012-11-04

Last Posted Date: 2023-05-22

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 10

Registration Number: NCT01721577

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Using Mobile Phones to Improve Adherence to Inhaled Steroids

Not Applicable

Completed

Conditions: Asthma

Interventions: Behavioral: Asthma Supervision
Behavioral: Mobile Phone
Behavioral: Inhaled Corticosteroid Mobile Phone Application
Behavioral: Beta2-adrenergic agonist Mobile Phone Application

First Posted Date: 2012-10-18

Last Posted Date: 2014-02-12

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 12

Registration Number: NCT01710059

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

Women's Walking Program

Not Applicable

Completed

Conditions: Cardiovascular Diseases

Interventions: Behavioral: Walking Program
Behavioral: Walking Program + Automated Calls
Behavioral: Walking Program + Motivational Interviewing Calls

First Posted Date: 2012-10-04

Last Posted Date: 2013-09-18

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 288

Registration Number: NCT01700894

Locations: 🇺🇸
Austin Health Center of Cook County Health & Hospitals System, Chicago, Illinois, United States
🇺🇸
University of Illinois at Chicago Mile Square Health Center at Back of the Yards, Chicago, Illinois, United States
🇺🇸
University of Illinois at Chicago Mile Square Health Center, Chicago, Illinois, United States

and more 4 locations

Efficacy and Patient Satisfaction of Miralax and Gatorade Versus Movi Prep

Phase 4

Completed

Conditions: Colorectal Cancer

Interventions: Drug: comparing 2 drugs on their effect on the bowel preparation for colonoscopy

First Posted Date: 2012-09-28

Last Posted Date: 2023-08-02

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 150

Registration Number: NCT01695863

Locations: 🇺🇸
Rush Unversity Medical Center, Chicago, Illinois, United States

Brain Network Activation Analysis to Diagnose/Assess Treatment of Unipolar Major Depression and Bipolar I Depression

Terminated

Conditions: Depression

First Posted Date: 2012-09-11

Last Posted Date: 2020-11-24

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 30

Registration Number: NCT01683214

Use of a Novel Fibrin Sealant in Total Knee Arthroplasty

Phase 2

Completed

Conditions: Osteoarthritis
Intraoperative Bleeding

Interventions: Drug: Evicel Fibrin Spray

First Posted Date: 2012-08-03

Last Posted Date: 2016-02-09

Lead Sponsor: Rush University Medical Center

Target Recruit Count: 73

Registration Number: NCT01656759

Locations: 🇺🇸
Rush Oak Park Hospital, Oak Park, Illinois, United States

The Impact of the Routine Aminophylline Administration Following Regadenoson Stress on SPECT Myocardial Perfusion

Phase 4

Withdrawn

Conditions: Coronary Artery Disease

Interventions: Drug: ASSUAGE Protocol

First Posted Date: 2012-08-02

Last Posted Date: 2021-10-11

Lead Sponsor: Rush University Medical Center

Registration Number: NCT01655524

Locations: 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy